QZahlen Vertex - 500 Beiträge pro Seite

[fisicella]

Hallo zusammen,
wer weiß wann die Quartalszahlen von Vertex veröffentlich werden und was ist zu erwarten?

Grüße

[Aktien-profi]

Am 25 Juli meldet Vertex Pharma. seine Quartaltszahlen.

Aktien-profi

[B1B2]

Friday July 14, 10:08 am Eastern Time
Press Release
SOURCE: Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Announces Two-for-One Stock Split

CAMBRIDGE, Mass., July 14 /CNW/ -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX - news) announced today that its Board of Directors has approved a two-for-one stock split of its common stock. The stock split will be in the form of a stock dividend, and new shares will be distributed on August 23, 2000 to holders of record as of the close of business on August 9, 2000. The stock split will increase the number of shares currently issued and outstanding from approximately 26.7 million shares to approximately 53.4 million shares.

Through this stock split, our goal is to increase the liquidity of Vertex common stock and to broaden our shareholder base, stated Joshua Boger, Ph.D., Chairman, President and CEO. "This stock split reflects our commitment to building shareholder value as well as our enthusiasm for Vertex`s opportunities for continued growth."

Vertex Pharmaceuticals Incorporated discovers, develops and markets small molecule drugs that address major unmet medical needs. Vertex has eight drug candidates in clinical development to treat viral diseases, inflammation, cancer, autoimmune diseases and neurological disorders. Vertex has created its pipeline using a proprietary, information-based approach to drug design that integrates multiple technologies in biology, chemistry and biophysics, aimed at increasing the speed and success rate of drug discovery. Vertex`s first approved product is Agenerase(TM) (amprenavir), an HIV protease inhibitor, which Vertex co-promotes with Glaxo Wellcome.

The foregoing information regarding Vertex`s business strategy is forward looking. While management will make its best efforts to be accurate in making forward-looking statements, any such statements are subject to risks and uncertainties that could cause Vertex`s actual results to vary materially. Investors are directed to consider risks and uncertainties discussed in Vertex documents filed with the Securities and Exchange Commission.

Vertex`s press releases are available at www.vpharm.com, or by fax-on- demand at [phone] - Code: 938395.

[kandre.astolany]

halte split für richtig (aus shareholder sicht)
für bios ist 120$ relativ hoch
60 oder vielleicht 55 bei 1:2 split hören sich da doch gut an
vor allem für leute die bios mit nachholbedarf suchen und das nicht gleich überreißen!!
andere meinungen dazu!!!

[Atze2]

Und warum fällt die Aktie bei dieser Nachricht? Ist doch komisch, oder?

[Atze2]

Ich habe festgestellt, daß Millenium auch gefallen ist. Also wird es wohl nur ein kleiner "Verschnaufer" bei den Biotechs sein.

Die Führungsspitze von Vertex hat ja schon einen positiven Ausblick auf die Quartalszahlen gegeben. Wenn dann am 25.7. die kompletten Quartalszahlen gemeldet werden, gibt es sicherlich noch einen Kurssprung nach oben, denke ich.

[interno]

So denke ich auch.So denken viele.Und wenn viele so denken wie du
und ich, werden einige gerissene Großanleger verkaufen und bei 85$
wieder einsteigen.